Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Journal of Medicinal Chemistry|August 15, 1997
Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorderM Bös, F Jenck, J R Martin, et al.Behavioural Pharmacology|December 5, 2000
Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophreniaG Le Pen, A J Grottick, G A Higgins, et al.European Journal of Pharmacology|August 8, 1996
A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activityJ Lundkvist, Z Chai, R Teheranian, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficaciesM Facklam, P Schoch, E P Bonetti, et al.Behavioural Brain Research|November 1, 1986
A neuropharmacological study of the periventricular neural substrate involved in flightP Schmitt, P Carrive, G Di Scala, et al.European Journal of Medicinal Chemistry|September 28, 2000
Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like propertiesJ Wichmann, G Adam, S Röver, et al.The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivoF M Dautzenberg, J Wichmann, J Higelin, et al.Journal of Medicinal Chemistry|February 7, 2001
High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptorS Röver, G Adam, A M Cesura, et al.Advances in Biochemical Psychopharmacology|January 1, 1992
Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disordersW Haefely, M Facklam, P Schoch, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 26, 1998
Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in ratsF Jenck, J L Moreau, H H Berendsen, et al.Pageof 7